Structure and dynamics of adeno-associated virus serotype 1 VP1-unique N-terminal domain and its role in capsid trafficking

Journal of Virology

Volumn 87, Issue 9, 2013, Pages 4974-4984

  Venkatakrishnan, Balasubramanian ^a,d   Yarbrough, Joseph ^a   Domsic, John ^a,e   Bennett, Antonette ^a   Bothner, Brian ^b   Kozyreva, Olga G ^c   Samulski, R Jude ^c   Muzyczka, Nicholas ^a   McKenna, Robert ^a   Agbandje McKenna, Mavis ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b MONTANA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d INDIANA UNIVERSITY   (United States)

^e WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN VP1; PROTEIN VP2; PROTEIN VP3;

ADENO ASSOCIATED VIRUS; ALPHA HELIX; AMINO TERMINAL SEQUENCE; ARTICLE; CELL MIGRATION; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOCYTOSIS; MATHEMATICAL ANALYSIS; MOLECULAR DYNAMICS; NONHUMAN; PH MEASUREMENT; PREDICTION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN REFOLDING; PROTEIN UNFOLDING; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; TEMPERATURE SENSITIVITY; VIRUS CAPSID; VIRUS MORPHOLOGY;

CAPSID; CAPSID PROTEINS; CIRCULAR DICHROISM; DEPENDOVIRUS; MICROSCOPY, ELECTRON; MODELS, MOLECULAR; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; VIRUS ASSEMBLY;

ADENO-ASSOCIATED VIRUS; MIRIDAE; PARVOVIRUS;

EID: 84876171439     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02524-12     Document Type: Article

References (71)

1. Atchison RW, Casto BC, Hammon WM.1965. Adenovirus-associated defective virus particles. Scienc tchison 149:754-755.
2. Buller RML, Janik JE, Sebring ED, Rose JA.1981. Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication J. Virol uller 40:241-247.
3. Geoffroy M.-C, Salvetti A.2005. Helper functions required for wild type and recombinant adeno-associated virus growth. Curr. Gene Ther. 5(part 6):265-271.
4. Walz C, Deprez A, Dupressoir T, Dürst M, Rabreau M, Schlehofer J.R.1997. Interaction of human papillomavirus type 16 and adeno-associated virus type 2 co-infecting human cervical epithelium. J. Gen. Virol alz 78,6:1441-1452.
5. Gao G, Vandenberghe L.H, Alvira M.R, Lu Y, Calcedo R, Zhou X, Wilson J.M.2004. Clades of adeno-associated viruses are widely disseminated in human tissues. J. Virol ao 78:6381-6388.
6. Mori S, Wang L, Takeuchi T, Kanda T.2004. Two novel adenoassociated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein. Virolog ori 330:375-383.
7. Schmidt M, Voutetakis A, Afione S, Zheng C, Mandikian D, Chiorini J.A.2008. Adeno-associated virus type 12 (AAV12): a novel AAV serotype with sialic acid- and heparan sulfate proteoglycan-independent transduction activity. J. Virol chmidt 82:1399-1406.
8. Burger C, Gorbatyuk O.S, Velardo M.J, Peden C.S, Williams P, Zolotukhin S, Reier P.J, Mandel R.J, Muzyczka N.2004. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol. Ther urger 10:302-317.
9. Davidson B.L, Stein C.S, Heth J.A, Martins I, Kotin R.M, Derksen T.A, Zabner J, Ghodsi A, Chiorini J.A.2000. Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc. Natl. Acad. Sci. U. S. A avidson 97:3428-3432.
10. Gao G.-P, Alvira M.R, Wang L, Calcedo R, Johnston J, Wilson J.M.2002. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. U. S. A ao 99:11854-11859.
11. Kaludov N, Brown K.E, Walters R.W, Zabner J, Chiorini J.A.2001. Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity. J. Virol aludov 75:6884-6893.
12. Rabinowitz J.E, Rolling F, Li C, Conrath H, Xiao W, Xiao X, Samulski R.2002. Cross-packaging of a single adeno-associated virus (AAV) type 2vector genome into multiple AAV serotypes enables transduction with broad specificity. J. Virol abinowitz 76:791-801.
13. Walters R.W, Yi S.M.P, Keshavjee S, Brown K.E, Welsh M.J, Chiorini J.A, Zabner J.2001. Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J. Biol. Chem alters 276:20610-20616.
14. Maguire A.M, Simonelli F, Pierce E.A, Pugh E.N, Mingozzi F, Bennicelli J, Banfi S, Marshall K.A, Testa F, Surace E.M, Rossi S, Lyubarsky A, Arruda V.R, Konkle B, Stone E, Sun J, Jacobs J, Dell'Osso L, Hertle R, Ma J, Redmond T.M, Zhu X, Hauck B, Zelenaia O, Shindler K.S, Maguire M.G, Wright J.F, Volpe N., McDonnell J.W, Auricchio A, High K.A, Bennett J.2008. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N. Engl. J. Med aguire 358:2240-2248.
15. Buller R.M, Rose J.A.1978. Characterization of adenovirus-associated virus-induced polypeptides in KB cells. J. Virol uller 25:331-338.
16. Johnson F.B, Ozer H.L, Hoggan M.D.1971. Structural proteins of adenovirus-associated virus type 3. J. Virol ohnson 8:860-863.
17. Rose J.A, Maizel J.V, Inman J.K, Shatkin A.J.1971. Structural proteins of adenovirus-associated viruses. J. Virol ose 8:766-770.
18. Lerch T.F, Xie Q, Chapman M.S.2010. The structure of adeno-associated virus serotype 3B (AAV-3B): insights into receptor binding and immune evasion. Virolog erch 403:26-36.
19. Miller E.B, Gurda-Whitaker B, Govindasamy L, McKenna R, Zolotukhin S, Muzyczka N, Agbandje-McKenna M.2006. Production, purification and preliminary X-ray crystallographic studies of adenoassociated virus serotype 1. Acta Crystallogr. Sect. F Struct. Biol. Cryst.Commun iller 62:1271-1274.
20. DiMattia M.A, Nam H.J, Van Vliet K, Mitchell M, Bennett A, Gurda B.L, McKenna R, Olson N.H, Sinkovits R.S, Potter M, Byrne B.J, Aslanidi G, Zolotukhin S, Muzyczka N, Baker TS, Agbandje-McKenna M.2012. Structural insight into the unique properties of adeno-associated virus serotype 9. J. Virol iMattia 86:6947-6958.
21. Nam H-J, Lane M.D, Padron E, Gurda B, McKenna R, Kohlbrenner E, Aslanidi G, Byrne B, Muzyczka N, Zolotukhin S, Agbandje-McKenna M.2007. Structure of adeno-associated virus serotype 8, a gene therapy vector. J. Virol am 81:12260-12271.
22. Ng R, Govindasamy L, Gurda B.L, McKenna R, Kozyreva O.G, Samulski R.J, Parent K.N, Baker T.S, Agbandje-McKenna M.2010. Structural characterization of the dual glycan binding adeno-associated virus serotype 6. J. Virol g 84:12945-12957.
23. Padron E, Bowman V, Kaludov N, Govindasamy L, Levy H, Nick P, McKenna R, Muzyczka N, Chiorini J.A, Baker T.S, Agbandje-McKenna M.2005. Structure of adeno-associated virus type 4. J. Virol adron 9:5047-5058.
24. Quesada O, Gurda B, Govindasamy L, McKenna R, Kohlbrenner E, Aslanidi G, Zolotukhin S, Muzyczka N, Agbandje-McKenna M.2007. Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 7. Acta Crystallogr. Sect. F Struct. Biol.Cryst. Commun uesada 63:1073-1076.
25. Walters R.W, Agbandje-McKenna M, Bowman V.D, Moninger T.O, Olson N.H, Seiler M, Chiorini J.A, Baker T.S, Zabner J.2004. Structure of adeno-associated virus serotype 5. J. Virol alters 78:3361-3371.
26. Xie Q, Bu W, Bhatia S, Hare J, Somasundaram T, Azzi A, Chapman M.S.2002. The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy. Proc. Natl. Acad. Sci. U. S. A ie 99:10405-10410.
27. Kronenberg S, Böttcher B, von der Lieth C.W, Bleker S, Kleinschmidt J.A.2005. A conformational change in the adeno-associated virus type 2 capsid leads to the exposure of hidden VP1 N termini. J. Virol ronenberg 79:5296-5303.
28. Sonntag F, Köther K, Schmidt K, Weghofer M, Raupp C, Nieto K, Kuck A, Gerlach B, Böttcher B, Müller O.J, Lux K, Hörer M, Kleinschmidt J.A.2011. The assembly-activating protein promotes capsid assembly of different adeno-associated virus serotypes. J. Virol onntag 85:12686-12697.
29. Agbandje-McKenna M, Kleinschmidt J.2011. AAV capsid structure and cell interactions. Methods Mol. Biol gbandje 807:47-92.
30. Bell C.L, Vandenberghe L.H, Bell P, Limberis M.P, Gao G.-P, Van Vliet K, Agbandje-McKenna M, Wilson J.M.2011. The AAV9 receptor and its modification to improve in vivo lung gene transfer in mice. J. Clin. Invest ell 121:2427-2435.
31. Dickey D.D, Excoffon K.J.D.A, Koerber J.T, Bergen J, Steines B, Klesney-Tait J, Schaffer D.V, Zabner J.2011. Enhanced sialic acid-dependent endocytosis explains the increased efficiency of infection of airway epithelia by a novel adeno-associated virus. J. Virol ickey 85:9023-9030.
32. Shen S, Bryant K.D, Brown S.M, Randell S.H, Asokan A.2011. Terminal N-linked galactose is the primary receptor for adeno-associated virus 9. J. Biol. Chem hen 286:13532-13540.
33. Summerford C, Samulski R.J.1998. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol ummerford 72:1438-1445.
34. Wu Z, Asokan A, Grieger JC, Govindasamy L, Agbandje-McKenna M, Samulski R.J.2006. Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypes. J. Virol u 80:11393-11397.
35. Wu Z, Miller E, Agbandje-McKenna M, Samulski R.J.2006. Alpha2,3 and alpha2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6. J. Virol u 80:9093-9103.
36. Asokan A, Hamra J.B, Govindasamy L, Agbandje-McKenna M, Samulski R.J.2006. Adeno-associated virus type 2 contains an integrin {alpha}5{beta}1 binding domain essential for viral cell entry. J. Virol sokan 80:8961-8969.
37. Qing K, Mah C, Hansen J, Zhou S, Dwarki V, Srivastava A.199 Humanfibroblast growth factor receptor 1 is a co-receptor for infection by deno-associated virus 2. Nat. Med ing 5:71-77.
38. Summerford C, Bartlett J.S, Samulski R.J.1999. AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nat. Med ummerford 5:78-82.
39. Di Pasquale G, Davidson BL, Stein CS, Martins I, Scudiero D, Monks A, Chiorini JA.2003. Identification of PDGFR as a receptor for AAV-5 transduction. Nat. Med i 9:1306-1312.
40. Akache B, Grimm D, Pandey K, Yant SR, Xu H, Kay MA.2006. The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9. J. Virol kache 80:9831-9836.
41. Uhrig S, Coutelle O, Wiehe T, Perabo L, Hallek M, Büning H.2012. Successful target cell transduction of capsid-engineered rAAV vectors requires clathrin-dependent endocytosis. Gene Ther hrig 19:210-218.
42. Nonnenmacher M, Weber T.2011. Adeno-associated virus 2 infection requires endocytosis through the CLIC/GEEC pathway. Cell Host Microb onnenmacher 10:563-576.
43. Xiao P-J, Samulski RJ.2012. Cytoplasmic trafficking, endosomal escape, and perinuclear accumulation of adeno-associated virus type 2 particles are facilitated by microtubule network. J. Virol iao 86:10462-10473.
44. Sonntag F, Bleker S, Leuchs B, Fischer R, Kleinschmidt JA.2006. Adeno-associated virus type 2 capsids with externalized VP1/VP2 trafficking domains are generated prior to passage through the cytoplasm and are maintained until uncoating occurs in the nucleus. J. Virol onntag 80:11040-11054.
45. Bleker S, Sonntag F, Kleinschmidt JA.2005. Mutational analysis of narrow pores at the fivefold symmetry axes of adeno-associated virus type2 capsids reveals a dual role in genome packaging and activation of phospholipase A2 activity. J. Virol leker 79:2528-2540.
46. Grieger JC, Johnson JS, Gurda-Whitaker B, Agbandje-McKenna M, Samulski RJ.2007. Surface-exposed adeno-associated virus Vp1-NLS capsid fusion protein rescues infectivity of noninfectious wild-type Vp2/Vp3 and Vp3-only capsids but not that of fivefold pore mutant virions. J.Virol rieger 81:7833-7843.
47. Grieger JC, Snowdy S, Samulski RJ.2006. Separate basic region motifs within the adeno-associated virus capsid proteins are essential for infectivity and assembly. J. Virol rieger 80:5199-5210.
48. Popa-Wagner R, Porwal M, Kann M, Reuss M, Weimer M, Florin L, Kleinschmidt JA.2012. Impact of VP1-specific protein sequence motifs on adeno-associated virus type 2 intracellular trafficking and nuclear entry. J. Virol opa 86:9163-9174.
49. Bartlett JS, Wilcher R, Samulski RJ.2000. Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors. J. Virol artlett 74:2777-2785.
50. Douar AM, Poulard K, Stockholm D, Danos O.2001. Intracellular trafficking of adeno-associated virus vectors: routing to the late endosomal compartment and proteasome degradation. J. Virol ouar 75:1824-1833.
51. Duan D, Yue Y, Yan Z, Yang J, Engelhardt JF.2000. Endosomal processing limits gene transfer to polarized airway epithelia by adenoassociated virus. J. Clin. Invest uan 105:1573-1587.
52. Hansen J, Qing K, Srivastava A.2001. Adeno-associated virus type 2-mediated gene transfer: altered endocytic processing enhances transduction efficiency in murine fibroblasts. J. Virol ansen 75:4080-4090.
53. Sanlioglu S, Benson PK, Yang J, Atkinson EM, Reynolds T, Engelhardt JF.2000. Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by Rac1 and phosphatidylinositol-3 kinase activation. J. Virol anlioglu 74:9184-9196.
54. Nam H-J, Gurda BL, McKenna R, Potter M, Byrne B, Salganik M, Muzyczka N, Agbandje-McKenna M.2011. Structural studies of adenoassociated virus serotype 8 capsid transitions associated with endosomal trafficking. J. Virol am 85:11791-11799.
55. Grieger JC, Choi VW, Samulski RJ.2006. Production and characterization of adeno-associated viral vectors. Nat. Protoc rieger 1:1412-1428.
56. Greenfield NJ, Fasman GD.1969. Computed circular dichroism spectra for the evaluation of protein conformation. Biochemistr reenfield 8:4108-4116.
57. Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins MR, Appel RD, Bairoch A.2005. Protein identification and analysis tools on the ExPASy server, p 571-607. In Walker JM (ed), The proteomics protocols handbook. Humana Press, Totowa, NJ
58. Jordan DO. 1955. The physical properties of nucleic acids, p 447-492. In Chargaff E, Davidson JN (ed), The nucleic acids. Academic Press Ltd., New York, NY.
59. Xue B, Dunbrack RL, Williams RW, Dunker AK, Uversky VN.2010. PONDR-FIT: a meta-predictor of intrinsically disordered amino acids.Biochim. Biophys. Act ue 1804:996-1010.
60. Kim DE, Chivian D, Baker D.2004. Protein structure prediction and analysis using the Robetta server. tNucleic Acids Res im 32:W526-W531.
61. Emsley P, Lohkamp B, Scott WG, Cowtan K.2010. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr msley 66:486-501.
62. Dijkstra BW, Kalk KH, Hol WG, Drenth J.1981. Structure of bovine pancreatic phospholipase A2 at 1.7A resolution. J. Mol. Biol ijkstra 147:97-123.
63. Okada T, Nonaka-Sarukawa M, Uchibori R, Kinoshita K, Hayashita-Kinoh H, Nitahara-Kasahara Y, Takeda S, Ozawa K.2009. Scalable purification of adeno-associated virus serotype 1 (AAV1) and AAV8 vectors,using dual ion-exchange adsorptive membranes. Hum. Gene Ther kada 20:1013-1021.
64. Gerlach B, Kleinschmidt JA, Böttcher B.2011. Conformational changes in adeno-associated virus type 1 induced by genome packaging. J. Mol. Biol erlach 409:427-438.
65. White S, Scott D, Otwinowski Z, Gelb M, Sigler P.1990. Crystal structure of cobra-venom phospholipase A2 in a complex with a transition-state analogue. Scienc hite 250:1560-1563.
66. Scott DL, Otwinowski Z, Gelb MH, Sigler PB.1990. Crystal structure of bee-venom phospholipase A2 in a complex with a transition-state analogue. Scienc cott 250:1563-1566.
67. Horowitz ED, Finn MG, Asokan A.2012. Tyrosine cross-linking reveals interfacial dynamics in adeno-associated viral capsids during infection. ACS Chem. Biol orowitz 7:1059-1066.
68. Levy HC, Bowman VD, Govindasamy L, McKenna R, Nash K, Warrington K, Chen W, Muzyczka N, Yan X, Baker TS, Agbandje-McKenna M.2009. Heparin binding induces conformational changes in Adenoassociated virus serotype 2. J. Struct. Biol evy 165:146-156.
69. Canaan S, Zádori Z, Ghomashchi F, Bollinger J, Sadilek M, Moreau ME, Tijssen P, Gelb MH.2004. Interfacial enzymology of parvovirus phospholipases A2. J. Biol. Chem anaan 279:14502-14508.
70. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE.2004. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem ettersen 25:1605-1612.
71. Govindasamy L, Padron E, McKenna R, Muzyczka N, Kaludov N, Chiorini JA, Agbandje-McKenna M.2006. Structurally mapping the diverse phenotype of adeno-associated virus serotype 4. J. Virol ovindasamy 80:11556-11570.